Diflucan Générique est un antifongique antibiotique. Il est utilisé pour traiter les infections causées par le fongus, qui peut envahir plusieurs parties du corps incluant la bouche, la gorge, l'oesophage, les poumons, la vessie, les parties génitales et le sang.
MethylGene présente ses résultats financiers du premier trimestre ... - LeLézard.com
MethylGene présente ses résultats financiers du premier trimestre .
Consider Narrow Fluconazole Strategy if Candida Incidence Is Low - Family Practice News Digital Network
Consider Narrow Fluconazole Strategy if Candida Incidence Is LowFamily Practice News Digital NetworkBOSTON – A narrow, targeted approach to fluconazole prophylaxis prevents most cases of neonatal candidiasis among extremely low-birth-weight infants in centers with a low incidence of the fungal infection, a study has shown.
Antibiotics boost risk of infection with antifungal-resistant candida - Medical Xpress
Antibiotics boost risk of infection with antifungal-resistant candidaMedical XpressRonen Ben-Ami of Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, and his colleagues identified 444 patients who had Candida growing in their blood; 8.
MethylGene Reports First Quarter 2012 Financial Results and ... - MarketWatch (press release)
MethylGene Reports First Quarter 2012 Financial Results and .
L&T Finance Q4 net up 45% - Business Standard (blog)
L&T Finance Q4 net up 45%Business Standard (blog)Meanwhile, JBCPL also expects to receive USFDA approval to manufacture and market the anti-fungal fluconazole tablets of 50 mg, 100 mg and 200 mg by December this year.